KRAS and malignant colon neoplasm: Anti-EGFR antibody, cetuximab or panitumumab is a treatment for colon cancer that is highly effective to patients with expression of EGFR protein; however, it has been reported that patients with KRAS gene mutations that lie downstream acquire resistance against therapy (5–7).